Opportunity Information: Apply for CDC RFA IP11 1103
Apply for CDC RFA IP11 1103
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Sustaining Influenza Surveillance Networks and Response to Seasonal and Pandemic Influenza by National Health Authorities outside the United States" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.283 Centers for Disease Control and PreventionInvestigations and Technical Assistance.
- This funding opportunity was created on Mar 3, 2011 and posted on Mar 3, 2011.
- Applicants must submit their applications by May 2, 2011. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $40,000,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $500,000.00 in funding.
- The number of recipients for this funding is limited to 21 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Eligible applicants Eligible applicants that can apply for this funding opportunity are listed below. Only the following Foreign Governments (who are completing four or five years under the announcements Cl06 607, IP07 702 and Cl06 603 and BTEP 107) may submit applications through their Ministries of Health or other national Government offices responsible for maintaining influenza surveillance systems for human disease Afghanistan, Angola, Argentina, Armenia, Bangladesh, Brazil, Cambodia, Cote D Ivoire, Democratic Republic of Congo, Ethiopia, Republic of Georgia, Mexico, Morocco, Nigeria, Peru, Russia, Rwanda, South Africa, Tanzania, Uganda and Ukraine.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The grant opportunity titled "Sustaining Influenza Surveillance Networks and Response to Seasonal and Pandemic Influenza by National Health Authorities outside the United States" is a CDC-funded cooperative agreement designed to help specific foreign national governments maintain and strengthen influenza surveillance capacity that was originally built under earlier CDC cooperative agreements (CI06-607, IP07-702, CI06-603) or through Biotechnology Engagement Program (BTEP) funding. The central idea is continuity: these countries already invested several years building surveillance networks and data systems, and this program is meant to keep those systems functioning, improve their quality and reach, and help countries transition from externally supported projects to nationally owned, routinely funded public health infrastructure. The surveillance focus covers seasonal influenza as well as novel strains with pandemic potential, emphasizing not just detection but also timely reporting and response planning.
The program is explicitly limited to a defined group of countries that are completing their fourth or fifth year under the prior CDC/BTEP efforts and are applying through their Ministries of Health or other national government offices responsible for human influenza surveillance. The eligible foreign governments listed are Afghanistan, Angola, Argentina, Armenia, Bangladesh, Brazil, Cambodia, Cote d'Ivoire, Democratic Republic of Congo, Ethiopia, Republic of Georgia, Mexico, Morocco, Nigeria, Peru, Russia, Rwanda, South Africa, Tanzania, Uganda, and Ukraine. In practical terms, that means the funding is not an open global competition; it is targeted continuation support for national authorities that already participated in earlier related initiatives and are expected to demonstrate progress and readiness to institutionalize the work.
Programmatically, the grant centers on sustaining and systematizing two core streams of influenza information: virological data (laboratory detection and characterization of influenza viruses) and epidemiological data (who is getting sick, where, when, and with what severity). The opportunity stresses the development and implementation of robust routine surveillance systems that function in a timely way, which typically implies standardized case definitions, sentinel site networks, reliable specimen collection and transport, laboratory testing capacity, consistent data management, and regular analysis and reporting. The inclusion of "seasonal, novel and pandemic influenza" signals that the surveillance systems should be flexible enough to handle routine annual influenza trends while also being capable of rapidly scaling or adapting during unusual events, such as the emergence of a new strain or an outbreak that could signal pandemic risk.
A key expectation is sustainability planning tied to national ownership. Applicants are expected to submit detailed plans showing how they will fully assume responsibilities and funding over time for maintaining influenza surveillance as a routine public health function. This often involves demonstrating how influenza surveillance is being integrated into national budgets, workforce planning, laboratory and epidemiology training pipelines, procurement and supply chains, and national reporting structures. The intent is to avoid building systems that fade when external funding ends, and instead move toward stable, domestically supported surveillance that continues year after year and remains functional during emergencies.
Administratively, this is a discretionary funding opportunity using a cooperative agreement mechanism, meaning CDC anticipates substantial involvement in the funded activities through technical assistance, coordination, and shared programmatic oversight rather than a hands-off grant. The opportunity is cataloged under CFDA 93.283 (CDC Investigations and Technical Assistance). There is no cost-sharing or matching requirement. The CDC projected up to 21 awards, aligning with the list of eligible countries, with an estimated total program funding level of $40,000,000. The award ceiling is listed as $500,000, and the award floor is $0, suggesting awards could vary by country and scope based on proposed activities and CDC priorities. The opportunity was posted March 3, 2011, with an original and current closing date of May 2, 2011, and an archive date of June 1, 2011.
Overall, this opportunity is best understood as a targeted sustainment and transition initiative: it builds on earlier investments in influenza surveillance networks, pushes countries to formalize and stabilize the systematic collection of influenza virologic and epidemiologic data, and requires realistic, detailed national plans to take over long-term responsibility for routine surveillance and readiness for seasonal outbreaks and pandemic threats. For applicants, the core challenge is not just proposing technical upgrades, but demonstrating that the surveillance system can be maintained reliably within national structures and funding streams, with the speed and quality needed for both everyday public health monitoring and high-stakes emergency response.
Frequently Asked Questions (FAQs)
What is the title of this grant opportunity?
The opportunity is titled "Sustaining Influenza Surveillance Networks and Response to Seasonal and Pandemic Influenza by National Health Authorities outside the United States."
Who is funding this opportunity?
This is a CDC-funded cooperative agreement.
What is the main purpose of the program?
The program is designed to help specific foreign national governments maintain and strengthen influenza surveillance capacity that was built under earlier CDC cooperative agreements (CI06-607, IP07-702, CI06-603) or through Biotechnology Engagement Program (BTEP) funding. The core theme is continuity and transition to nationally owned, routinely funded public health infrastructure.
Is this an open global competition?
No. This is explicitly limited to a defined group of eligible foreign governments that previously participated in related CDC/BTEP efforts and are completing their fourth or fifth year under those efforts.
Which countries are eligible to apply?
The eligible foreign governments listed are Afghanistan, Angola, Argentina, Armenia, Bangladesh, Brazil, Cambodia, Cote d'Ivoire, Democratic Republic of Congo, Ethiopia, Republic of Georgia, Mexico, Morocco, Nigeria, Peru, Russia, Rwanda, South Africa, Tanzania, Uganda, and Ukraine.
Who within an eligible country is expected to apply?
Applications are expected to be submitted through Ministries of Health or other national government offices responsible for human influenza surveillance.
What kinds of influenza does the surveillance focus on?
The surveillance focus covers seasonal influenza as well as novel strains with pandemic potential, emphasizing detection, timely reporting, and response planning.
What are the two core streams of information the program emphasizes?
The opportunity centers on sustaining and systematizing (1) virological data (laboratory detection and characterization of influenza viruses) and (2) epidemiological data (who is getting sick, where, when, and with what severity).
What does "virological data" mean in this program context?
Virological data refers to laboratory-based detection and characterization of influenza viruses, supported by functioning specimen collection and testing capacity.
What does "epidemiological data" mean in this program context?
Epidemiological data refers to information that helps describe illness patterns in people, including who is affected, geographic distribution, timing, and severity.
What types of surveillance systems does the CDC expect applicants to develop or maintain?
The opportunity stresses robust routine surveillance systems that function in a timely way. This typically implies standardized case definitions, sentinel site networks, reliable specimen collection and transport, laboratory testing capacity, consistent data management, and regular analysis and reporting.
Why does the opportunity emphasize both seasonal and pandemic influenza?
The inclusion of "seasonal, novel and pandemic influenza" indicates the surveillance systems should support routine annual monitoring while remaining flexible enough to scale or adapt quickly during unusual events (such as the emergence of a new strain or an outbreak signaling pandemic risk).
What is meant by "sustainability" and "national ownership" in this grant?
Sustainability and national ownership refer to transitioning influenza surveillance from externally supported projects to stable, domestically supported public health functions that continue year after year and remain functional during emergencies.
What is expected in a sustainability plan?
Applicants are expected to submit detailed plans showing how they will fully assume responsibilities and funding over time for maintaining influenza surveillance as a routine public health function, including integration into national budgets, workforce planning, training pipelines, procurement and supply chains, and national reporting structures.
What is the funding mechanism for this opportunity?
This is a discretionary funding opportunity using a cooperative agreement mechanism.
What does it mean that this is a cooperative agreement?
A cooperative agreement means CDC anticipates substantial involvement in funded activities through technical assistance, coordination, and shared programmatic oversight, rather than a fully hands-off grant structure.
What is the CFDA number for this opportunity?
The opportunity is listed under CFDA 93.283 (CDC Investigations and Technical Assistance).
Is cost-sharing or matching required?
No. The opportunity states there is no cost-sharing or matching requirement.
How many awards does CDC expect to make?
CDC projected up to 21 awards, aligning with the list of eligible countries.
What is the estimated total funding for the program?
The estimated total program funding level is $40,000,000.
What is the maximum award amount (award ceiling)?
The award ceiling is listed as $500,000.
What is the minimum award amount (award floor)?
The award floor is listed as $0, indicating awards could vary by country and scope depending on proposed activities and CDC priorities.
When was the opportunity posted?
The opportunity was posted March 3, 2011.
What is the closing date for applications?
The original and current closing date is May 2, 2011.
When was the opportunity archived?
The archive date is June 1, 2011.
What is the overall goal for participating countries by the end of this support period?
The overall goal is to sustain and improve existing influenza surveillance networks and data systems while demonstrating progress and readiness to institutionalize the work within national structures and funding streams.
What is the central challenge for applicants described in the opportunity summary?
The core challenge is not only proposing technical improvements, but also demonstrating that surveillance can be maintained reliably within national systems and funding, with the speed and quality needed for everyday monitoring and emergency response.
Browse more opportunities from the same agency: Centers for Disease Control and Prevention
Browse more opportunities from the same category: Health
Next opportunity: EONS 2011 SSC Pre Service Teacher Institute (SSC PSTI)
Previous opportunity: Environmental Education Regional Grants Solicitation Notice for 2011
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA IP11 1103
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA IP11 1103) also looked into and applied for these:
| Funding Opportunity |
|---|
| Morris K. Udall Centers of Excellence for Parkinsons Disease Research (P50) Apply for RFA NS 11 004 Funding Number: RFA NS 11 004 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| FY 2011 Cooperative Agreements for the National Suicide Prevention Lifeline Crisis Center Follow Up Apply for SM 11 004 Funding Number: SM 11 004 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $360,000 |
| Strengthening the Capacity of Local Indigenous Faith Based Partners in Zambia to Provide HIV/AIDS Prevention, Treatment and Care Services in a Comprehensive and Sustainable Manner under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH11 1120 Funding Number: CDC RFA GH11 1120 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Partnerships for Biodefense (R01) Apply for RFA AI 11 014 Funding Number: RFA AI 11 014 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Economics of Retirement (R01) Apply for PA 11 138 Funding Number: PA 11 138 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Economics of Retirement (R03) Apply for PA 11 139 Funding Number: PA 11 139 Agency: National Institutes of Health Category: Health Funding Amount: $50,000 |
| Economics of Retirement (R21) Apply for PA 11 140 Funding Number: PA 11 140 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Cooperative Agreement with the South Africa National Health Laboratory Service (NHLS) Apply for CDC RFA GH11 1199 Funding Number: CDC RFA GH11 1199 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Part D Coordinated HIV Services and Access to Research for WICY One Time Supplemental Funds Apply for HRSA 11 094 Funding Number: HRSA 11 094 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Affordable Care Act Program for Early Detection of Certain Medical Conditions Related to Environmental Health Hazards Apply for CDC RFA TS11 1102PPHF11 Funding Number: CDC RFA TS11 1102PPHF11 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $2,500,000 |
| Competitive Revision Applications for NIDCR funded Cooperative Agreements (U01) Apply for PAR 11 144 Funding Number: PAR 11 144 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Research Centers for Excellence in Clinical Preventive Services (P01) Apply for RFA HS 11 005 Funding Number: RFA HS 11 005 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| The Infant Immune System Implications for Vaccines and Response to Infections (R01) Apply for RFA AI 11 010 Funding Number: RFA AI 11 010 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| International Research in Infectious Diseases, including AIDS (R01) Apply for PAR 11 145 Funding Number: PAR 11 145 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Centers for Education and Research on Therapeutics (CERTs) Scientific Forum (U19) Apply for RFA HS 11 003 Funding Number: RFA HS 11 003 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| Centers for Education and Research on Therapeutics (CERTs)( U19) Apply for RFA HS 11 004 Funding Number: RFA HS 11 004 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| Cooperative Agreement to Support State Assessment Initiatives Apply for CDC RFA HK07 70205CONT11 Funding Number: CDC RFA HK07 70205CONT11 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| HAITI REHABILITATION AND REINTEGRATION OF PERSONS WITH DISABILITIES PROGRAM Apply for USAID HAITI RFA 521 10 033 Funding Number: USAID HAITI RFA 521 10 033 Agency: Haiti USAID Port Au Prince Category: Health Funding Amount: $9,000,000 |
| NINDS Cooperative Program in Translational Research Single Component Research Projects (U01) Apply for PAR 11 153 Funding Number: PAR 11 153 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NINDS Cooperative Program in Translational Research for Resistant Epilepsy and Epileptogenesis (U01) Apply for PAR 11 154 Funding Number: PAR 11 154 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA IP11 1103", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
